Hoth Therapeutics, Inc. (HOTH) SEC Filings — 2024
14 SEC filings for Hoth Therapeutics, Inc. (HOTH) in 2024.
Filings
- Hoth Therapeutics Amends Q3 2024 Financial Filing — 8-K · Dec 2, 2024
- Hoth Therapeutics Files 8-K — 8-K · Nov 20, 2024
- Hoth Therapeutics Files Q3 2024 10-Q Report — 10-Q · Nov 12, 2024
- Hoth Therapeutics Files 8-K — 8-K · Nov 8, 2024
- Hoth Therapeutics Faces Delisting Concerns — 8-K · Nov 1, 2024
- Hoth Therapeutics Files Q2 2024 10-Q Report — 10-Q · Aug 9, 2024
- Hoth Therapeutics Files 8-K on Security Holder Votes — 8-K · Aug 7, 2024
- Hoth Therapeutics Files 2024 Proxy Statement — DEF 14A · Jun 18, 2024
- Hoth Therapeutics Relocates Executive Offices — 8-K · Jun 17, 2024
- Hoth Therapeutics, Inc. Files 10-Q for Period Ended March 31, 2024 — 10-Q · May 14, 2024
- Hoth Therapeutics Files S-1 for Potential Stock Offering — S-1 · Apr 11, 2024
- Hoth Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
- Hoth Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Hoth Therapeutics Files 8-K: Administrative Update, Nasdaq Listing Confirmed — 8-K · Jan 9, 2024